This website uses cookies to enhance the user experience.
V

VT KARDIO HOLDING AS912 412 288

Research
Limited company
Bolignummer K20 Armauer Hansens hus Haukelandsbakken 28 5009 BERGEN, Norge

VT KARDIO HOLDING AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

CEO
Chairman of the board
Years since formation
11 years
since Sep 9, 2013
Type
Limited company
VAT registered
No
Number of employees
0

Ownership

Number of shares and share classes
30,000
1 share class
Total number of shareholders
1
person
Belongs to group of

Financials

Annual total result 2023
-14,835
NOK
Total equity 2023
246,653
NOK
Last update: Aug 29, 2024

Management

Management / administration

NameRoleShares
Managing Director/CEO
100 %
directly

Board

NameRoleShares
Chairman
100 %
directly

Others

NameRoleShares
A
AIDER AS
Accountant-

Top 10 individual shareholders

NameRoleShares
Managing Director/CEO, Chairman
100 %
directly
Last update: Dec 16, 2023

Ownership

Company shareholders

NameShare classNumber of sharesShare
Ordinary shares
30,000
100 %

Shares owned by the VT KARDIO HOLDING AS

NameShare classNumber of sharesShare
V
VT KARDIO KONSULENT AS
Ordinary shares
30,000
100 %
S
SPINLOOP AS
Ordinary shares
30,000
100 %
C
CINCH MEDICAL AS
Ordinary shares
11,250
37.5 %
N
NUHEART AS
Ordinary shares
24,000,000
6.66 %
Last update: May 24, 2024

Group structure

  • Total operating income 2023: NOK 0
    Operating profit 2023: NOK -33,878
    Employees: 0

Financials

in NOK

Summary

Year202320222021
Total operating income
0
0
0
Annual Total Result
-14,835
-1,275
376,524
Total assets
944,244
561,954
926,520
Total liabilities
697,591
300,466
363,758
Total equity
246,653
261,487
562,762

P&L

Year202320222021
Total operating income
0
0
0
Total operating costs
33,878
15,153
8,859
Operating result
-33,878
-15,153
-8,859
Financial income/costs
19,043
13,878
551,805
Profit before tax
-14,835
-1,275
542,946
Total tax & extraordinary income/cost
0
0
166,422
Annual Total Result
-14,835
-1,275
376,524

Balance overview

Year202320222021
Total fixed assets
160,001
30,001
30,001
Total current assets
784,243
531,953
896,519
Total assets
944,244
561,954
926,520
Short term debt
697,591
300,466
166,633
Long term debt
0
0
197,125
Total liabilities
697,591
300,466
363,758
Contributed capital
12,418
12,418
12,418
Retained earnings
234,235
249,069
550,344
Total equity
246,653
261,487
562,762
Total equity and liabilities
944,244
561,954
926,520

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology